Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02891811
Title Patients With Newly Diagnosed Multiple Myeloma Comparing KTd vs. KRd Induction Therapy and Investigating a K-mono Maintenance Strategy
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Arbeitsgemeinschaft medikamentoese Tumortherapie

multiple myeloma


Carfilzomib + Dexamethasone + Lenalidomide

Carfilzomib + Dexamethasone + Thalidomide

Age Groups: adult | senior
Covered Countries DEU | AUT

No variant requirements are available.